Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards
article has not abstract
Vyšlo v časopise:
Dissemination of Research Findings to Research Participants Living with HIV in Rural Uganda: Challenges and Rewards. PLoS Med 10(3): e32767. doi:10.1371/journal.pmed.1001397
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001397
Souhrn
article has not abstract
Zdroje
1. JonesL, WellsK (2007) Strategies for academic and clinician engagement in community-participatory partnered research. JAMA 297: 407–410.
2. JacobST, BaetenJM, HughesJP, PeinadoJ, WangJ, et al. (2011) A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial. AIDS Behav 15: 897–904.
3. RamjeeG, GovindenR, MorarNS, MbewuA (2007) South Africa's experience of the closure of the cellulose sulphate microbicide trial. PLoS Med 4: e235 doi:10.1371/journal.pmed.0040235.
4. DarbyshireJL, PriceHC (2012) Disseminating results to clinical trial participants: a qualitative review of patient understanding in a post-trial population. BMJ Open 2.
5. Mfutso-BengoJ, NdebeleP, MasiyeF (2008) Disseminating research results to research participants and their communities. Malawi Med J 20: 64–66.
6. WallinAM, AhlstromG (2006) Cross-cultural interview studies using interpreters: systematic literature review. J Adv Nurs 55: 723–735.
7. WareNC, IdokoJ, KaayaS, BiraroIA, WyattMA, et al. (2009) Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 6: e11 doi:10.1371/journal.pmed.1000011.
8. AdakunS, SiednerM, MuzooraC, HabererJ, TsaiA, et al. (2013) Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. JAIDS In press. Epub 2012 Dec 13.
9. OyugiJH, Byakika-TusiimeJ, RaglandK, LaeyendeckerO, MugerwaR, et al. (2007) Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 21: 965–971.
10. HabererJE, KahaneJ, KigoziI, EmenyonuN, HuntP, et al. (2010) Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 14: 1340–1346.
11. SiednerMJ, LankowskiA, MusingaD, JacksonJ, MuzooraC, et al. (2012) Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS ONE 7: e45643 doi:10.1371/journal.pone.0045643.
12. HuntPW, CaoHL, MuzooraC, SsewanyanaI, BennettJ, et al. (2011) Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 25: 2123–2131.
13. TsaiAC, BangsbergDR, FrongilloEA, HuntPW, MuzooraC, et al. (2012) Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda. Soc Sci Med 74: 2012–2019.
14. WeiserSD, GuptaR, TsaiAC, FrongilloEA, GredeN, et al. (2012) Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda. J Acquir Immune Defic Syndr 61: 179–186.
15. WeiserSD, TsaiAC, GuptaR, FrongilloEA, KawumaA, et al. (2012) Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting. AIDS 26: 67–75.
16. TsaiAC, BangsbergDR, EmenyonuN, SenkunguJK, MartinJN, WeiserSD (2011) The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. SocSci Med 73: 1717–1724.
17. SiednerMJ, TsaiAC, DworkinS, MukiibiNF, EmenyonuNI, et al. (2012) Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav 16: 1542–1548.
18. Matthews L, Kaida A, Byakwaga H, Kanters S, Muzoora C, et al.. (2012) Increased risk of mortality associated with pregnancy and the post-partum period in a cohort of HIV-1-infected women on antiretroviral treatment in Uganda. International AIDS Conference. Washington DC.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 3
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Surveillance Programme of IN-patients and Epidemiology (SPINE): Implementation of an Electronic Data Collection Tool within a Large Hospital in Malawi
- Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
- Strengthening the Expanded Programme on Immunization in Africa: Looking beyond 2015
- The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies